Dr. Vance Thompson Among First U.S. Surgeons to Implant BVI FineVision® Lens

Dr. Vance Thompson

On Monday, February 2nd, Dr. Vance Thompson successfully performed one of the first BVI FineVision® HP Trifocal Intraocular Lens (IOL) implantations in the United States. This milestone marks a significant milestone in the advancement of vision correction for U.S. patients.

The FDA-approved BVI FineVision® HP Trifocal IOL offers patients improved vision at near, intermediate, and distance ranges, providing a full range of vision and reducing their dependence on glasses and contact lenses after cataract surgery. 

“We pride ourselves on treating patients with the most advanced technology,” said Dr. Thompson. “The FineVision HP Trifocal IOL is another avenue for us to achieve this, and give patients an improved quality of life. ”

This implantation helps expand broader U.S. availability of the BVI FineVision HP Trifocal IOL and highlights the ongoing evolution of premium cataract and refractive lens surgery.

“This is a really exciting step forward for us and our patients,” he continued. “The more ways we can provide clearer vision, the more people we can help—and that’s what matters most to us.”